Panagora Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.14M	Sell	313,700 -11,046	-3%	-$328K	0.02%	381
2025 Q4	$10.1M	Sell	324,746 -52,965	-14%	-$1.45M	0.04%	292
2025 Q3	$8.15M	Buy	377,711 +25,859	+7%	+$466K	0.03%	298
2025 Q2	$4.92M	Sell	351,852 -2,887	-0.8%	-$39.2K	0.02%	336
2025 Q1	$4.78M	Buy	354,739 +101,717	+40%	+$1.73M	0.02%	345
2024 Q4	$4.85M	Buy	253,022 +84,589	+50%	+$1.84M	0.02%	346
2024 Q3	$3.83M	Buy	+168,433	New	+$2.75M	0.02%	395
2020 Q3	–	Sell	-151	Closed	-$3K	–	2764
2020 Q2	$3K	Hold	151	–	–	﹤0.01%	2447
2020 Q1	$1K	Hold	151	–	–	﹤0.01%	2456
2019 Q4	$1K	Hold	151	–	–	﹤0.01%	2416
2019 Q3	$2K	Buy	+151	New	+$3.34K	﹤0.01%	2377
2018 Q3	–	Sell	-383	Closed	-$37K	–	2470
2018 Q2	$37K	Sell	383 -212	-36%	-$22.4K	﹤0.01%	2097
2018 Q1	$63K	Hold	595	–	–	﹤0.01%	1967
2017 Q4	$93K	Sell	595 -16	-3%	-$2.04K	﹤0.01%	1899
2017 Q3	$84K	Sell	611 -153	-20%	-$25.7K	﹤0.01%	1930
2017 Q2	$148K	Buy	764 +743	+3,538%	+$125K	﹤0.01%	1760
2017 Q1	$4K	Buy	+21	New	+$3.62K	﹤0.01%	2314